|
Volumn 16, Issue 4, 2005, Pages 565-571
|
Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
ENZYME INHIBITOR;
N(G) NITROARGININE METHYL ESTER;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
BLADDER TUMOR;
C57BL MOUSE;
CANCER TRANSPLANTATION;
CELL SURVIVAL;
COMPARATIVE STUDY;
CYTOLOGY;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
INTRALESIONAL DRUG ADMINISTRATION;
METABOLISM;
MOUSE;
PATHOLOGY;
PERITONEUM MACROPHAGE;
SPLEEN;
TIME;
TREATMENT OUTCOME;
TUMOR CELL LINE;
ANIMALS;
BCG VACCINE;
CELL LINE, TUMOR;
CELL SURVIVAL;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
INJECTIONS, INTRALESIONAL;
MACROPHAGES, PERITONEAL;
MICE;
MICE, INBRED C57BL;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, EXPERIMENTAL;
NG-NITROARGININE METHYL ESTER;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
SPLEEN;
TIME FACTORS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
EID: 33644680754
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (17)
|
References (0)
|